IL33 and breast carcinoma: Pro-tumor: IL-33/ILC2 axis facilitates tumor growth and metastasis by recruiting MDSCs to produce IL-13. Pro-tumor: ILC2s promote breast cancer growth by upregulating Tregs through ICOS/ICOSL interaction.